{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T17:55:13Z","timestamp":1755798913144,"version":"3.44.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","funder":[{"name":"Research and Development Plan of Key Fields in Hunan Province","award":["2020SKC2007"],"award-info":[{"award-number":["2020SKC2007"]}]},{"name":"Science Research Fund of AIER Eye Hospital Group","award":["AF2201D12"],"award-info":[{"award-number":["AF2201D12"]}]},{"name":"Clinic Research Foundation of Aier Eye Hospital Group","award":["AIG2304D03"],"award-info":[{"award-number":["AIG2304D03"]}]},{"name":"Clinic Research Foundation of Aier Eye Hospital Group","award":["AGK2301D13"],"award-info":[{"award-number":["AGK2301D13"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To investigate changes in aqueous humor matrix metalloproteinases (MMPs) after intravitreal ranibizumab (IVR) therapy, and their correlations with imaging parameters in retinal vein occlusion (RVO).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Aqueous humor samples from 28 patients with RVO were collected at baseline, 1, and 2 months after IVR therapy. MMP-1, -2, -3, -7, -8, -9, -10, TIMP-1, and VEGF-A levels were measured using Luminex \u00d7 MAP. Participants were categorized as responders or nonresponders based on \u2265 30% central retinal thickness (CRT) reduction at month 2. MMPs and TIMP-1 changes were analyzed. Correlations between baseline MMP-1, MMP-2, TIMP-1, and retinal structural and microvascular parameters were assessed. Multivariate regression analyzed associations with treatment response.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Intraocular MMP-1, MMP-2, and TIMP-1 levels significantly decreased in responders but not in nonresponders. Baseline MMP-1, MMP-2, and TIMP-1 were positively correlated with CRT, IS\u2013OS and ELM disruption, DRIL, and SRD height (all <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05). Negative correlations were observed between MMP-1 (r = \u22120.520, <jats:italic toggle=\"yes\">P<\/jats:italic> = 006), TIMP-1 (r = \u22120.416, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.039), and FAZ size. Higher baseline MMP-1 (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.024) and lower TIMP-1 (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.034) levels were associated with greater CRT reduction.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Aqueous humor levels of MMP-1, MMP-2, and TIMP-1 are associated with in macular edema, retinal damage, and microvascular changes in RVO. Baseline MMP-1 and TIMP-1 may serve as potential biomarkers for predicting short-term therapeutic response.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000004522","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T16:00:07Z","timestamp":1747152007000},"page":"1790-1798","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["DYNAMIC CHANGES OF AQUEOUS MATRIX METALLOPROTEINASES AND IMAGING CORRELATION IN RETINAL VEIN OCCLUSION AFTER RANIBIZUMAB THERAPY"],"prefix":"10.1097","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4418-6474","authenticated-orcid":false,"given":"Yanying","family":"Zhao","sequence":"first","affiliation":[{"name":"Aier Academy of Ophthalmology, Central South University, Changsha, China;"},{"name":"Changsha Aier Eye Hospital, Changsha, China;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Guo","sequence":"additional","affiliation":[{"name":"Changsha Aier Eye Hospital, Changsha, China;"},{"name":"Aier Eye Hospital, Jinan University, Guangzhou, China;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengnan","family":"Liang","sequence":"additional","affiliation":[{"name":"Aier Academy of Ophthalmology, Central South University, Changsha, China;"},{"name":"Changsha Aier Eye Hospital, Changsha, China;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[{"name":"Changsha Aier Eye Hospital, Changsha, China;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengwei","family":"Ge","sequence":"additional","affiliation":[{"name":"Changsha Aier Eye Hospital, Changsha, China;"},{"name":"Aier Eye Hospital, Jinan University, Guangzhou, China;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heping","family":"Xu","sequence":"additional","affiliation":[{"name":"Aier Academy of Ophthalmology, Central South University, Changsha, China;"},{"name":"Aier Eye Institute, Changsha, China;"},{"name":"The Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongping","family":"Chen","sequence":"additional","affiliation":[{"name":"Aier Academy of Ophthalmology, Central South University, Changsha, China;"},{"name":"Changsha Aier Eye Hospital, Changsha, China;"},{"name":"Aier Eye Hospital, Jinan University, Guangzhou, China;"},{"name":"School of Stomatology and Ophthalmology, Xianning Medical College, Hubei University of Science and Technology, Xianning, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250819","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/APO.0000000000000598","article-title":"Update on retinal vein occlusion","volume":"12","author":"Romano","year":"2023","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"R2-20250819","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(20)31559-2","article-title":"Retinal vascular occlusions","volume":"396","author":"Scott","year":"2020","journal-title":"Lancet"},{"key":"R3-20250819","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.2165\/00003495-200767080-00007","article-title":"Ranibizumab","volume":"67","author":"Blick","year":"2007","journal-title":"Drugs"},{"key":"R4-20250819","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ajo.2019.03.029","article-title":"Loss of peak vision in retinal vein occlusion patients treated for macular edema","volume":"205","author":"Iftikhar","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"R5-20250819","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.3390\/ijms21249739","article-title":"The roles of matrix metalloproteinases and their inhibitors in human diseases","volume":"21","author":"Cabral-Pacheco","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R6-20250819","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.nbd.2008.08.005","article-title":"Blood-brain barrier tight junction permeability and ischemic stroke","volume":"32","author":"Sandoval","year":"2008","journal-title":"Neurobiol Dis"},{"key":"R7-20250819","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/svn-2023-002363","article-title":"Implications of MMP-12 in the pathophysiology of ischaemic stroke","volume":"9","author":"Veeravalli","year":"2024","journal-title":"Stroke Vasc Neurol"},{"key":"R8-20250819","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1007\/s00018-019-03177-3","article-title":"Metalloproteinases mediate diabetes-induced retinal neuropathy and vasculopathy","volume":"76","author":"Opdenakker","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"R9-20250819","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1111\/aos.13451","article-title":"Differential expression and localization of human tissue inhibitors of metalloproteinases in proliferative diabetic retinopathy","volume":"96","author":"Abu El-Asrar","year":"2018","journal-title":"Acta Ophthalmologica"},{"key":"R10-20250819","first-page":"1","article-title":"Changes in aqueous and vitreous inflammatory cytokine levels in proliferative diabetic retinopathy: a systematic review and meta-analysis","author":"Mason","year":"2022","journal-title":"Eye"},{"key":"R11-20250819","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1136\/bjophthalmol-2019-315358","article-title":"Higher aqueous levels of matrix metalloproteinases indicated visual impairment in patients with retina vein occlusion after anti-VEGF therapy","volume":"105","author":"Luo","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"R12-20250819","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.3390\/jcm9113457","article-title":"Cytokines and pathogenesis of central retinal vein occlusion","volume":"9","author":"Noma","year":"2020","journal-title":"J Clin Med"},{"key":"R13-20250819","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/s41433-022-02007-4","article-title":"Retinal vein occlusion (RVO) guideline: executive summary","volume":"36","author":"Nicholson","year":"2022","journal-title":"Eye (Lond)"},{"key":"R14-20250819","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ophtha.2013.08.038","article-title":"Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN study","volume":"121","author":"Campochiaro","year":"2014","journal-title":"Ophthalmology"},{"key":"R16-20250819","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nrd2308","article-title":"Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases","volume":"6","author":"Hu","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"R17-20250819","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/cvr\/cvm102","article-title":"Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead","volume":"78","author":"van Hinsbergh","year":"2008","journal-title":"Cardiovasc Res"},{"key":"R18-20250819","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.critrevonc.2003.10.004","article-title":"Matrix metalloproteinases and matrikines in angiogenesis","volume":"49","author":"Bellon","year":"2004","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"R19-20250819","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0955-0674(00)00248-9","article-title":"Matrix metalloproteinases: they\u2019re not just for matrix anymore","volume":"13","author":"McCawley","year":"2001","journal-title":"Curr Opin Cell Biol"},{"key":"R20-20250819","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.3390\/biom12101368","article-title":"Matrix metalloproteinases and glaucoma","volume":"12","author":"Kim","year":"2022","journal-title":"Biomolecules"},{"key":"R21-20250819","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1038\/s41433-022-02265-2","article-title":"Longitudinal analysis of aqueous humour cytokine expression and OCT-based imaging biomarkers in retinal vein occlusions treated with anti-vascular endothelial growth factor therapy in the IMAGINE study","volume":"37","author":"Arepalli","year":"2023","journal-title":"Eye (Lond)"},{"key":"R22-20250819","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/s41433-020-1100-0","article-title":"Sequential restoration of external limiting membrane and ellipsoid zone after intravitreal anti-VEGF therapy in diabetic macular oedema","volume":"35","author":"De","year":"2021","journal-title":"Eye (Lond)"},{"key":"R23-20250819","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1001\/jamaophthalmol.2014.2350","article-title":"Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema","volume":"132","author":"Sun","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"R24-20250819","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.oret.2019.08.009","article-title":"Spectral-domain OCT predictors of visual outcomes after ranibizumab treatment for macular edema resulting from retinal vein occlusion","volume":"4","author":"Yiu","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"R25-20250819","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ajpath.2010.11.003","article-title":"Increased expression of matrix metalloproteinase-1 in systemic vessels of preeclamptic women: a critical mediator of vascular dysfunction","volume":"178","author":"Estrada-Gutierrez","year":"2011","journal-title":"Am J Pathol"},{"key":"R26-20250819","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.lfs.2019.05.038","article-title":"MMP targeting in the battle for vision: recent developments and future prospects in the treatment of diabetic retinopathy","volume":"229","author":"Drankowska","year":"2019","journal-title":"Life Sci"},{"key":"R27-20250819","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/labinvest.3700251","article-title":"Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier","volume":"85","author":"Giebel","year":"2005","journal-title":"Lab Invest"},{"key":"R28-20250819","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.2337\/db06-1694","article-title":"Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes","volume":"56","author":"Navaratna","year":"2007","journal-title":"Diabetes"},{"key":"R29-20250819","doi-asserted-by":"crossref","first-page":"8703","DOI":"10.3390\/ijms21228703","article-title":"Matrix metalloproteinases MMP-2 and MMP-9, their inhibitors TIMP-1 and TIMP-2, vascular endothelial growth factor and sVEGFR-2 as predictive markers of ischemic retinopathy in patients with systemic sclerosis\u2014case series report","volume":"21","author":"Waszczykowska","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R30-20250819","doi-asserted-by":"crossref","first-page":"98113611","DOI":"10.1155\/2021\/9811361","article-title":"Ocular TGF-\u03b2, matrix metalloproteinases, and TIMP-1 increase with the development and progression of diabetic retinopathy in type 2 diabetes mellitus","volume":"2021","author":"Saucedo","year":"2021","journal-title":"Mediators Inflamm"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004522","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T15:00:42Z","timestamp":1755615642000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004522","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"type":"print","value":"0275-004X"},{"type":"electronic","value":"1539-2864"}],"subject":[],"published":{"date-parts":[[2025,9]]}}}